ZORIFERTINIB

Clinical trials for ZORIFERTINIB explained in plain language.

Never miss a new study

Get alerted when new ZORIFERTINIB trials appear

Sign up with your email to follow new studies for ZORIFERTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for lung cancer patients with brain-spread disease

Disease control Not yet recruiting

This phase 2 trial tests a combination of the drug zorifertinib plus chemotherapy delivered directly into the fluid around the brain and spine. It is for people with a specific type of lung cancer (NSCLC with EGFR mutation) whose cancer has spread to the lining of the brain and s…

Matched conditions: ZORIFERTINIB

Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC

ZORIFERTINIB

Get alerted when new ZORIFERTINIB trials appear

New hope for lung cancer patients with brain-spread disease